Seeking New Users for iSeq
The Changing Sequencing Landscape
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
For full access to this article login to GEN Select now.
New Antibody Engineering Technologies
More Effective and Targeted Therapeutics Viewed As Anticipated Outcomes
- New approaches to antibody engineering were presented at the “European Antibody Congress” held in Geneva, Switzerland last month. At the meeting, companies grappled with long-standing issues of glycosylation, antibody structures, alternative structures, and novel purification approaches. While the mechanism of tumor-cell destruction by therapeutic antibodies is not completely ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.